|
|
|
|
| Tell us what you think
|
|
|
| Home
|
|
|
Demographics and Health Effects Key findings, Recommendations, Slide kit
|
|
|
Efficacy Key findings, Recommendations, Areas for further research, Slide kit
|
|
|
Health Economics Key findings, Recommendations, Areas for further research
|
|
|
Policy Key findings, Recommendations, Areas for further research, Slide kit
|
|
|
Safety Key findings, Recommendations, Areas for further research, Slide kit
|
|
|
| Resource library
|
|
|
| Useful organisations
|
|
|
| About Us
|
|
|
|
|

The demand for nicotine replacement therapies (NRT) is directly related
to the level of third-party coverage for NRT products, and inversely
related to out-of-pocket costs.Individuals who face decreased out-of-pocket costs for obtaining NRT
products from either insurers or employers are more likely to use NRT,
use NRT for longer periods of time, and subsequently use more units of
NRT than individuals who face higher out-of-pocket costs.
Over-the-counter (OTC) availability of nicotine gum and nicotine
patches increased the proportion of smokers using the patch and gum in
the period immediately following approval of OTC sale in California;
there was also a significantly higher proportion of smokers reporting
abstinence through gum and patch use in that period. Making smokers
aware of insurance coverage for a pharmacotherapy benefit (such as NRT,
bupropion or varenicline) and making it very easy to obtain the
medication increases use of the medication and quit rates, even in the
absence of insurance coverage for behavioral counseling. However,
simply providing coverage for pharmacotherapy, without extraordinary
efforts to make smokers aware of the covered benefit and making it easy
to obtain, was not shown to increase the use of medication and quit
rates. - Cox JL, McKenna JP. Nicotine gum: Does providing it
free in a smoking cessation program alter success rates. J Fam Pract
1990; 31: 278-280.
http://www.findarticles.com/p/articles/mi_m0689/is_n3_v31/ai_8955494
- Curry SJ, Grothaus LC, McAfee T, Pabiniak C. Use
and cost effectiveness of smoking-cessation services under four
insurance plans in a health maintenance organization. N Engl J Med
1998; 339 : 673-679.
http://content.nejm.org/cgi/content/full/339/10/673
- Hughes JR, Wadland WC, Fenwick JW, Lewis J, Bickel
WK. Effects of cost on the self administration and efficacy of nicotine
gum: a preliminary study. Preventive Medicine 1991; 20: 486-496.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1908080&dopt=Abstract
- Johnson RE, Hollis JF, Stevens VJ, Woodson GT.
Patterns of nicotine gum use in a health maintenance organization. Ann
Pharmacother 1991; 25: 730-735.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1949928&dopt=Abstract
- Solberg LI. Impact of insurance coverage on the
use and effects of smoking cessation medications. Dis Manage Health
Outcomes 2005; 3 (13); 151-158.
|